Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Scott Ernst, D.; F. Tannock, I.; Winquist, Eric; Venner, Peter; Reyno, Leonard; J. Moore, Malcolm; Chi, K.N.; Ding, Keyue; Gregory Elliott, C.; R. Parulekar, Wendy

doi:10.1200/jco.2003.03.042

Public

Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and Pain

Published in Journal of Clinical Oncology • Aug 28, 2003

Authors:

D. Scott Ernst

I. F. Tannock

Eric Winquist

Abstract

PURPOSE: To compare the incidence of palliative response in patients with hormone-resistant prostate cancer (HRPC) treated with mitoxantrone and prednisone (MP) plus clodronate with that of patients treated with MP plus placebo. MATERIALS AND METHODS: Men with HRPC, bone metastases, and bone pain we...

Subject

Medicine

Mitoxantrone

Placebo

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!